BCR::ABL1-dependent mechanisms are the most common and well-studied mechanisms of TKI resistance in CML that reactivate the kinase activity of BCR::ABL1 [32,33]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.